Related Experiment Video
Updated: Mar 7, 2026

Long-Term Continuous Measurement of Renal Blood Flow in Conscious Rats
Published on: February 8, 2022
Metformin-associated lactic acidosis treated with continuous renal replacement therapy
Akihide Nakamura1,2, Kei Suzuki1,2, Hiroshi Imai2
1Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan.
Metformin-associated lactic acidosis (MALA) is a rare emergency. Continuous renal replacement therapy (CRRT) effectively treated a severe MALA case, stabilizing the patient and normalizing lactate levels.
Area of Science:
- Nephrology
- Critical Care Medicine
- Pharmacology
Background:
- Metformin-associated lactic acidosis (MALA) is a rare, life-threatening condition.
- Early recognition and prompt management are crucial for patient survival.
Observation:
- A 71-year-old male presented with non-specific gastrointestinal symptoms, progressing to catecholamine-resistant shock and severe lactic acidosis.
- Standard treatments including bicarbonate and antibiotics provided no clear benefit.
Findings:
- Urgent continuous renal replacement therapy (CRRT) was initiated due to hemodynamic instability and metabolic acidosis.
- CRRT rapidly reduced lactate levels, with complete normalization of pH within 18 hours, leading to patient stabilization.
Implications:
- MALA can present with subtle, non-specific symptoms, necessitating consideration in cases of unexplained metabolic acidosis.
- CRRT is a valuable therapeutic option for severe MALA, especially in hemodynamically unstable patients.
- Emergency physicians must be familiar with MALA as a critical medical emergency.
Related Concept Videos
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Chronic Kidney Disease I: Introduction
